<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although the prevalence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) is rising no data exist for racial minorities on prevalence in the general population </plain></SENT>
<SENT sid="1" pm="."><plain>Minorities have a lower prevalence than Caucasians, and yet age, smoking, abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo>, and Helicobacter pylori are <z:hpo ids='HP_0000001'>all</z:hpo> risk factors </plain></SENT>
<SENT sid="2" pm="."><plain>Metabolic changes induced by adipocytokines and the apparently strong association between <z:hpo ids='HP_0001513'>obesity</z:hpo>, central <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, and BE may lead to reconsideration of some aspects of the natural history of BE </plain></SENT>
<SENT sid="3" pm="."><plain>There is lack of experimental evidence on acid sensitivity and BE, which is hyposensitive compared to <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">esophageal reflux disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Reactive nitrogen and oxygen species lead to impaired expression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, which can lead to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development; thus, <z:chebi fb="11" ids="22586">antioxidants</z:chebi> may be protective </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> may be considered an <z:mpath ids='MPATH_194'>immune-mediated disease</z:mpath> starting at the submucosal layer; the cytokine profile of the mucosal immune response may explain the different outcome of <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> </plain></SENT>
</text></document>